ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

NARecruitingINTERVENTIONAL

Enrollment

2,395

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

November 17, 2026

Study Completion Date

November 17, 2026

Conditions

OncologyExtravasation

Interventions

DEVICE

ivWatch

Patients wear ivWatch device at time of already scheduled chemotherapy on study.

Trial Locations (1)

RECRUITING

Roswell Park Comprehensive Cancer Center, Buffalo

All Listed Sponsors

lead

Roswell Park Cancer Institute

OTHER